Aducanumab (Aduhelm) for the Treatment of Alzheimers: A Podcast with Aaron Kesselheim and Jason Karlawish
On June 7th, 2021 FDA approved the amyloid beta-directed antibody aducanumab (Aduhelm) for the Treatment of Alzheimers. This approval of…
On June 7th, 2021 FDA approved the amyloid beta-directed antibody aducanumab (Aduhelm) for the Treatment of Alzheimers. This approval of…
In a new study in JAGS, Matthew Growdon found that the average number of medications people with dementia took in…
There are no currently approved disease modifying drugs for Alzheimer’s disease, but in a couple months that may change. In July…
Where are we with Alzheimers? Are we about to see a revolution in how we diagnose and treat it with Amyloid…
Surrogate decision‐making around life-sustaining treatments in the hospital even in the best of circumstances is hard. It’s maybe even harder…
“Diagnose and adios.” That’s the sad phrase that I’ve heard quoted more than once, representing caregivers’ sentiment of what it’s…
Chris Callahan (of Indiana University) and Lee Jennings (University of Oklahoma) have some righteous anger. Why do we have comprehensive cancer…
On this week’s podcast we have the honor of talking with David Reuben about health care for older adults and…
Do you remember the scene from the movie The Graduate where Ben’s dad says, “One word: Plastics”? Well, I write…
As Eric notes in the introduction, this recent study in JAMA by Jeff Williamson and colleagues led to some very…